The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,030.00
Bid: 2,000.00
Ask: 2,030.00
Change: 40.00 (2.01%)
Spread: 30.00 (1.50%)
Open: 2,000.00
High: 2,030.00
Low: 2,000.00
Prev. Close: 1,990.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

7 Dec 2017 07:00

RNS Number : 6235Y
S & U PLC
07 December 2017
 

7th December 2017

 

 

S&U plc

("S&U"or "the Group")

 

 

TRADING STATEMENT

 

S&U plc, the specialist hire purchase motor finance and property bridging lender, announces its trading update for the period from 1st August to 6th December 2017 and is pleased to continue trading in line with expectations.

 

Motor Finance

Advantage Finance, our specialist motor finance provider based in Grimsby continues its excellent progress. Despite recent downgraded forecasts for the UK economy, Advantage applications for finance have been very good. This has enabled Advantage both to maintain this year's rate of transactions growth and to revise, refine and further strengthen its under-writing model.

 

As a result, live customer numbers have grown to 53,000 from 49,000 at the half year; this means that net customer receivables now stand at over £240m for the first time, compared to nearly £227m in July.

 

Monthly collections and overall credit quality remain good. Whilst rolling 12 months impairment to revenue has increased slightly to 23.4%, this continues to be primarily due to overall portfolio product mix.

 

Whilst the above underwriting refinements have seen a slight reduction in loan approvals, appropriate in a more uncertain economic climate, the introduction of Advantage's new e-signature Dealfo system has been well received by both customers and brokers and has led to an improvement in the approval-transaction rate.

 

Property Bridging Finance

Our pilot bridging operation, Aspen Finance, has made significant progress and increased its loan book to £9m from £2m in July. Margins and LTV are within budget and very early repayment experience is good.

 

Aspen's growing reputation for efficient, consistent and prompt service to the broking community, augers well for a successful trial period concluding in H2 2018.

 

Funding

Having obtained further funding of £20m during the period, the Group now has total available committed facilities of £115m, sufficient to accommodate current growth at both Advantage and Aspen. Further facilities will be arranged as required.

 

Commenting on the Group's performance and outlook, Anthony Coombs, S&U Chairman, said:

 

"Whatever the current political uncertainty, particularly over Brexit, and despite a forecast slowing economy, demand for S&U's products remains very robust. Our selective lending and continuous refinement of our under-writing underpin our debt quality and produce steady sustainable growth.

 

"I am pleased to see this seemingly becoming more widely recognised within the investing community; we will continue our high standards of responsible lending and the excellent performance which results from this."

 

For further information, please contact:

 

S&U plc: www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Peel Hunt

Adrian Trimmings/Rishi Shah 020 7418 8900

 

Media and Investor Relations

Ged Brumby 020 3047 2527

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBIBDDRBGBGRL
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.